pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
789
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
TEB-17231
Solid Tumor
280Bio Inc
0
catalysts
Phase 1
TGI-2
Metastatic Colorectal Cancer
Hefei TG ImmunoPharma Co Ltd
0
catalysts
Phase 1
TGNS-11
Head And Neck Squamous Cell Carcinoma (HNSC)
Toragen Inc
0
catalysts
Phase 1
TGW-101
← prev
page 21 of 27
next →
131
Pain
89
Neurology
1
Castration-Resistant Prostate Cancer (CRPC)
Tagworks Pharmaceuticals BV
0
catalysts
Phase 1
TIX-100
Type 1 Diabetes (Juvenile Diabetes)
Tiximed Inc
0
catalysts
Phase 1
TLX-090
Cyclosam
Bone Metastasis
$TLX
Telix Pharmaceuticals Ltd
0
catalysts
Phase 1
TLY-012
Chronic Pancreatitis
D&D Pharmatech Co Ltd
0
catalysts
Phase 1
TML-6
Alzheimer's Disease
Merry Life Biomedical Co Ltd
0
catalysts
Phase 1
TN-301
Diastolic Heart Failure (HFpEF)
$TNYA
Tenaya Therapeutics, Inc.
0
catalysts
Phase 1
TNM-005
Varicella Zoster (HHV-3) Infections
Zhuhai Trinomab Pharmaceutical Co Ltd
0
catalysts
Phase 1
TNX-1500
Heart Transplant Rejection
$TNXP
Tonix Pharmaceuticals Holding Corp.
0
catalysts
Phase 1
TNX-4800
Lyme Disease
$TNXP
Tonix Pharmaceuticals Holding Corp.
0
catalysts
Phase 1
TOFACITINIB CITRATE
TOFACITINIB CITRATE (TOFACITINIB CITRATE)
Atopic Dermatitis (Atopic Eczema)
Janus Kinase (JAK)
$SIGY
Sigyn Therapeutics, Inc.
0
catalysts
Phase 1
TORL-2307 MAB
Gastric Cancer
TORL Biotherapeutics LLC
0
catalysts
Phase 1
TP-317
Crohn's Disease (Regional Enteritis)
Thetis Pharmaceuticals LLC
0
catalysts
Phase 1
TPIV-110
Ductal Carcinoma In Situ
$MRKR
Marker Therapeutics, Inc.
0
catalysts
Phase 1
TPST-1495
Adenocarcinoma Of The Gastroesophageal Junction
$TPST
Tempest Therapeutics, Inc.
0
catalysts
Phase 1
TRE-515
Ovarian Cancer
Trethera Corp
0
catalysts
Phase 1
TRL-345
Cytomegalovirus (HHV-5) Infections
Trellis Bioscience Inc
0
catalysts
Phase 1
TRV-045
Diabetic Neuropathic Pain
Trevena Inc
0
catalysts
Phase 1
TRX-920
Unspecified Cancer
TaiRx Inc
0
catalysts
Phase 1
TSC-203 HLA-A*02:01
Head And Neck Cancer
$TCRX
TScan Therapeutics, Inc.
0
catalysts
Phase 1
TSN-084
Triple-Negative Breast Cancer (TNBC)
Tyligand Biotechnology (Shanghai) Co Ltd
0
catalysts
Phase 1
TST-004
IgA Nephropathy (Berger's Disease)
Transcenta Holding Ltd
0
catalysts
Phase 1
TT-00920
Congestive Heart Failure (Heart Failure)
TransThera Sciences (Nanjing) Inc
0
catalysts
Phase 1
TT-01488
Diffuse Large B-Cell Lymphoma
TransThera Sciences (Nanjing) Inc
0
catalysts
Phase 1
TT-125
Non-Small Cell Lung Cancer
TOLREMO Therapeutics AG
0
catalysts
Phase 1
TTC-352
Metastatic Breast Cancer
TTC Oncology LLC
0
catalysts
Phase 1
TTI-109
Fibrosis
$TVRD
Tvardi Therapeutics, Inc.
0
catalysts
Phase 1
TTX-080
Acral Lentiginous Melanoma
Tizona Therapeutics Inc
0
catalysts
